Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Total 13F shares
-
2,491,723
-
Share change
-
+2,481,523
-
Total reported value
-
$3,670,000
-
Price per share
-
$1.48
-
Number of holders
-
16
-
Value change
-
+$3,654,972
-
Number of buys
-
15
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q3 2021
As of 30 Sep 2021,
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,491,723 shares.
The largest 10 holders included
Owl Creek Asset Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Shaolin Capital Management LLC, UBS OCONNOR LLC, ZAZOVE ASSOCIATES LLC, Maven Securities LTD, RIVERNORTH CAPITAL MANAGEMENT, LLC, Walleye Capital LLC, and Bulldog Investors, LLP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.